Remdesivir Recruiting Phase 3 Trials for Covid-19 ARDS / Coronavirus Disease 2019 (COVID‑19) Treatment

Indications	Status	Purpose	Phase
DBCOND0135643 (Covid-19 ARDS) DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19))	Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT04678739	Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial	Remdesivir (DB14761) Tocilizumab (DB06273)
NCT04693026	Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients	Baricitinib (DB11817) Remdesivir (DB14761) Tocilizumab (DB06273)